NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
123 hedge funds and large institutions have $607M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 50 increasing their positions, 28 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
123
Holders Change
+9
Holders Change %
+7.89%
% of All Funds
2.08%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
26
Increased
50
Reduced
28
Closed
15
Calls
$2.08M
Puts
–
Net Calls
+$2.08M
Net Calls Change
+$2.04M
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Allianz Asset Management
Munich,
Germany
| – | -$733K | -48,070 | Closed |
|
|
HS
127
HighVista Strategies
Boston,
Massachusetts
| – | -$705K | -46,243 | Closed |
|
128
Squarepoint
New York
| – | -$591K | -38,747 | Closed |
|
|
PP
129
PDT Partners
New York
| – | -$582K | -38,179 | Closed |
|
|
TI
130
Trexquant Investment
Stamford,
Connecticut
| – | -$383K | -25,147 | Closed |
|
131
Ohio Public Employees Retirement System (OPERS)
Columbus,
Ohio
| – | -$279K | -18,277 | Closed |
|
|
PHK
132
Point72 Hong Kong
Hong Kong
| – | -$31K | -2,034 | Closed |
|
|
PGAM
133
Princeton Global Asset Management
Princeton,
New Jersey
| – | -$24K | -1,600 | Closed |
|
|
BFC
134
Bedel Financial Consulting
Indianapolis,
Indiana
| – | -$2K | -100 | Closed |
|